TrialStem cell research & therapy2026

Efficacy and safety of allogeneic umbilical cord blood mononuclear cells therapy in children with autism spectrum disorder and immune dysregulation: a single-center, double-blinded, randomized, placebo-controlled trial.

Ziyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.